Tonomy

Company Overview

Snapshot

Founded in November 2017 by Gil Shamai and Niv Narkiss, Tonomy operates with 1–10 employees. The company secured its Seed funding round in December 2017 from the Israel Innovation Authority and MindUP.

Business overview

Tonomy develops a non-contact home tonometer and app designed to enable individuals to measure their intra-ocular pressure (IOP) at home. This technology aims to reduce the risk and improve the management of glaucoma by providing users with diagnostic data to share with their physicians for treatment. The company's proprietary tonometer solutions facilitate automatic and autonomous IOP testing and offer partnership opportunities with other monitoring device companies. Tonomy operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices, diagnostics, and digital healthcare, including patient remote monitoring.

Company Intelligence Q&A

What is Tonomy's primary focus?

Tonomy focuses on developing a non-contact home tonometer and a complementary app to allow individuals to measure their intra-ocular pressure (IOP) at home, aiming to reduce glaucoma risks and improve its management.

When was Tonomy founded and by whom?

Tonomy was founded in November 2017 by co-founders Gil Shamai and Niv Narkiss.

What is the current operational status of Tonomy?

Tonomy is currently non-active, having ceased operations in April 2024.

Which investors participated in Tonomy's Seed funding round?

Tonomy secured Seed funding in December 2017 from the Israel Innovation Authority and MindUP.

What kind of technology does Tonomy develop?

Tonomy develops proprietary tonometer solutions that enable automatic and autonomous intra-ocular pressure (IOP) testing, along with a mobile application for data management.